ArticleBMC medical research methodology2025
Enhancing interpretability for Bayesian basket trial designs by effective sample size.
Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThere is growing interest in utilizing Bayesian approaches to borrow information across tumor types in basket trials. Several innovative designs, primarily extensions of the Bayesian hierarchical model (BHM), have been proposed to dynamically borrow information based on observed data. However, there is no recognized solution to quantify the degree of information borrowing in such a context, posing a great challenge for non-statisticians to understand these complex designs.
methodsThe tool of effective sample size (ESS) is leveraged to Bayesian basket trials and several ESS-based borrowing strategies are proposed. The mean squared error (MSE), which explicitly accounts for the trade-off between estimation bias and variance reduction, is selected as the target measure for deriving ESS. Through a reanalysis of the RAGNAR study as well as simulation studies, the interpretability of ESS is demonstrated at both the analysis and design stages of basket trials.
resultsESS reflects the impact of information borrowing on MSE and intuitively characterizes the degree of borrowing. It aligns with the type I error rate and power, showing potential as a valuable complement in statistical analyses and simulation studies.
conclusionsQuantifying the degree of information borrowing by ESS can greatly help trialists design Bayesian basket trials, reasonably evaluate and interpret the results of Bayesian analyses, conduct sensitivity analyses, and ultimately borrow proper amount of information in basket trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.